Profile of ligand specificity of the vitamin D binding protein for 1α,25-dihydroxyvitamin d3 and its analogs
- 1 August 1994
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 9 (8) , 1277-1288
- https://doi.org/10.1002/jbmr.5650090818
Abstract
The profile of structural preference for the ligand binding domain of the human vitamin D binding protein (DBP) was determined by steroid competition assay of 71 analogs of 1α,25‐dihydroxyvitamin D3 [1α,25(OH)2D3]. The following categories of structural modification were evaluated [values represent fold change; R = reduction, I = increase in binding to the DBP from the reference 1α,25(OH)2D3]: (1) deletion in the A ring of the 1α‐hydroxyl (20‐1600I); (2) conversion of the triene system to the previtamin form (6‐40R); (3) addition of substituents to carbon 11 of the C ring (4‐14R); (4) inversion of the C/D ring junction (8‐20R); (5) unsaturation of the D ring (16‐ene; 4‐140R); (6) replacement of hydrogen with deuterium atoms (no effect); alteration of the side chain by (7) adding or deleting carbon atoms (5‐12R); (8) addition of fluorines (0.2‐10R); (9) presence of unsaturation (22‐ene, 0‐5R; 23‐ene, 3R‐10I; 23‐yne, 5‐20R); (10) addition of hydroxyls (2‐100R); and (11) addition of an aromatic ring (0‐20I). Thus the DBP ligand binding domain could tolerate only modest changes to the structure of 1α,25(OH)2D3 without a reduction in binding of the analog. The increases in binding seen in the aromatic side chain and with a triple bond at carbon‐23 may be indicative of a preferred conformation of the flexible 1α,25(OH)2D3 side chain. In addition, a comparison was made of the DBP ligand binding domain with that of the human HL‐60 cell 1α,25(OH)2D3 nuclear receptor. Both ligand binding domains could equivalently accommodate to the presence of (1) a side‐chain cyclopropyl group, (2) 22‐ene or 23‐yne, (3) lengthening the side chain by two carbons, (4) presence of four to six fluorine atoms, (5) substitution of an oxygen for carbon 22, and (6) presence of a 22‐[m‐(dimethylhydroxymethyl)phenyl] aromatic group in the side chain. The DPB could tolerate better than the HL‐60 cell receptor the presence of a 22‐(p‐hydroxyphenyl) aromatic group in the side chain and the absence of the 1α‐hydroxyl. In contrast, the HL‐60 cell receptor could tolerate better than the DBP the following structural modifications: presence of a 16‐ene, or 16‐ene plus 23‐yne unsaturation, and presence of an 11β‐hydroxyl.Keywords
Funding Information
- USPHS (DK-09012 (Norman), DK-16595 (Okamura), CA-43,277 (Norman and Okamura))
This publication has 32 references indexed in Scilit:
- Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (Gc-globulin)Biochemistry, 1992
- Immunomodulatory role of 1,25‐dihydroxyvitamin D3Journal of Cellular Biochemistry, 1992
- Vitamin D analogs with low affinity for the vitamin D binding protein: Enhanced in vitro and decreased in vivo activityJournal of Bone and Mineral Research, 1991
- Photoaffinity labeling of human serum vitamin D binding protein and chemical cleavages of the labeled protein: identification of an 11.5-KDa peptide containing the putative 25-hydroxyvitamin D3 binding siteBiochemistry, 1991
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.The Journal of cell biology, 1984
- Comparative study of the affinity of the serum vitamin d-binding proteinThe Journal of Steroid Biochemistry and Molecular Biology, 1980
- Binding specificity of the rat serum vitamin D transport proteinThe Journal of Steroid Biochemistry and Molecular Biology, 1980
- Studies on the mode of action of calciferol XIX. A 24R-hydroxyl-group can replace the 25-hydroxyl-group of 1α,25-dihydroxyvitamin D3 for optimal binding to the chick intestinal receptorBiochemical and Biophysical Research Communications, 1979
- The transport of vitamin D and its 25-hydroxy metabolite in human plasma. Isolation and partial characterization of vitamin D and 25-hydroxyvitamin D binding protein.Journal of Clinical Investigation, 1976